Safety and Efficacy of Istaroxime for Patients with Acute-Heart-Failure-Related Pre-cardiogenic Shock - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study (SEISMiC)
Academic Article
Publication Date:
2022
Short description:
Safety and Efficacy of Istaroxime for Patients with Acute-Heart-Failure-Related Pre-cardiogenic Shock - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study (SEISMiC) / Metra, Marco; Chioncel, Ovidiu; Cotter, Gad; Davison, Beth; Filippatos, Gerasimos; Mebazaa, Alexandre; Novosadova, Maria; Ponikowski, Piotr; Simmons, Phillip; Soffer, Joseph; Simonson, Steven. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2022). [10.1002/ejhf.2629]
abstract:
We examined the effects of istaroxime in patients hospitalized for acute heart failure (AHF) related Society for Cardiovascular Angiography and Interventions (SCAI) stage B pre-cardiogenic shock (CS).
Iris type:
1.1 Articolo in rivista
Keywords:
Acute heart failure; Blood pressure; Cardiogenic shock; Istaroxime; SERCA2a; Therapeutics
List of contributors:
Metra, Marco; Chioncel, Ovidiu; Cotter, Gad; Davison, Beth; Filippatos, Gerasimos; Mebazaa, Alexandre; Novosadova, Maria; Ponikowski, Piotr; Simmons, Phillip; Soffer, Joseph; Simonson, Steven
Published in: